Targeted radionuclide therapy for bone metastases
- 1 January 1993
- journal article
- review article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 20 (1) , 66-74
- https://doi.org/10.1007/bf02261248
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- 14. Is 89Sr an effective alternative to radiotherapy for prostatic metastases?Nuclear Medicine Communications, 1992
- A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153 ethylenediaminetetramethylene phosphonateEuropean Journal of Cancer and Clinical Oncology, 1991
- A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to boneEuropean Journal of Cancer and Clinical Oncology, 1991
- Review article : Pain in prostatic cancerPalliative Medicine, 1990
- LONG-TERM EFFECTS OF PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CL2MBP) ON BONE DISEASE OF MYELOMA PATIENTS TREATED WITH CHEMOTHERAPYHematological Oncology, 1990
- PAMIDRONATE TO REDUCE BONE PAIN IN NORMOCALCAEMIC PATIENT WITH DISSEMINATED PROSTATIC CARCINOMAThe Lancet, 1989
- Continuing care: a major issue in cancer pain managementPain, 1989
- Treatment of metastatic bone pain with strontium-89International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1987
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- Pain in far-advanced cancerPain, 1982